

HY-19350 · 10 mM * 1 mL in DMSO
MedChemExpress · Cat: HY-19350
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/BML-210.html
Description
BML-210 is a potent HDAC inhibitor. BML-210 can inhibit the HDAC4-VP16-driven reporter signal with an apparent IC50 of ?5?AAasAasAAmuM. BML-210 has a specific disruptive effect on the HDAC4:MEF2 interaction. BML-210 causes an increase in the G0/G1 phase. BML-210 induces apoptosis and displays antitumour activities in orthotopic mammary tumours in mice.







